1fab Acknowledgements | Updates in Oncology 2026 | Perelman School of Medicine at the University of Pennsylvania

Acknowledgements

We Gratefully Acknowledge the Following Company for Providing an Educational Grant 

AstraZeneca

We Gratefully Acknowledge the Following Companies for Providing Exhibit Support 

AbbVie Hematology

Abbvie Solid Tumors

Adaptive Biotechnologies

ADC Therapeutics

Agios Pharmaceuticals

Amgen Thoracic Oncology

Amgen Hematology Oncology

Astellas Oncology

AstraZeneca

AstraZeneca G2 Oncology

AstraZeneca Lung Cancer Portfolio

AstraZeneca Oncology Breast Portfolio

AstraZeneca Oncology GI

Autolus

Azurity Pharmaceuticals

Bayer Pharmaceuticals

BeOne Medicines

Blueprint Medicines

Boehringer Ingelheim

Bristol Myers Squibb Hematology

Bristol Myers Squibb Oncology

Daiichi Sankyo(2)

Eisai

Exelixis

Gamida Cell

Genentech

Genmab

Geron

Gilead Oncology

GSK

Guardant Health

Immunocore

Incyte

Incyte Hematology GVH/MPN

Iovance

Ipsen Biopharmaceuticals

Jazz Pharmaceuticals

Johnson & Johnson

Karyopharm Therapeutics

Kyowa Kirin

Lilly

Merck

Natera

Novartis CAR-T

Novartis Oncology

Novocure

Nuvation Bio

Pfizer Oncology

Pfizer Oncology Breast

Pfizer Precision Medicine

Pharmacyclics, an AbbVie Company

PharmaEssentia

Regeneron

Replimune

Sanofi

SecuraBio

Servier Pharmaceutical

Sobi

SpringWorks Therapeutics

Stemline

Sumitomo Pharma

Syndax Pharmaceutical

Taiho Oncology

Takeda Oncology Solid Tumor

Takeda Oncology Hematology

 

 

7 0